李 博, 赵吉祥, 陈杖榴, 路文华, 韩可可, 徐 维, 陈 红. 三氮脒在猪血浆的药物 - 蛋白结合研究[J]. 华南农业大学学报, 2014, 35(2): 24-27. DOI: 10.7671/j.issn.1001-411X.2014.02.005
    引用本文: 李 博, 赵吉祥, 陈杖榴, 路文华, 韩可可, 徐 维, 陈 红. 三氮脒在猪血浆的药物 - 蛋白结合研究[J]. 华南农业大学学报, 2014, 35(2): 24-27. DOI: 10.7671/j.issn.1001-411X.2014.02.005
    LI Bo, ZHAO Jixiang, CHEN Zhangliu, LU Wenhua, HAN Keke, XU Wei, CHEN Hong. Drug-protein binding of diminazene in swine plasma[J]. Journal of South China Agricultural University, 2014, 35(2): 24-27. DOI: 10.7671/j.issn.1001-411X.2014.02.005
    Citation: LI Bo, ZHAO Jixiang, CHEN Zhangliu, LU Wenhua, HAN Keke, XU Wei, CHEN Hong. Drug-protein binding of diminazene in swine plasma[J]. Journal of South China Agricultural University, 2014, 35(2): 24-27. DOI: 10.7671/j.issn.1001-411X.2014.02.005

    三氮脒在猪血浆的药物 - 蛋白结合研究

    Drug-protein binding of diminazene in swine plasma

    • 摘要: 【目的】研究三氮脒临床用药的有效性和安全性,测定猪血浆的药物-蛋白结合率.【方法】血浆样品以超滤法分离游离型的药物.以高效液相色谱-紫外法测定药物含量,计算出三氮脒-血浆蛋白结合率.6头猪交叉分别按体质量肌内注射7和14 mg/kg三氮脒注射液,在给药后3、5、15、60 min测定体内三氮脒-血浆蛋白结合率.【结果和结论】体外测定的三氮脒-血浆药物蛋白结合率为74.68%~95.90%.猪给药后体内的药物蛋白结合率为84.11%~89.69%(7 mg/kg剂量组)、82.96%~88.65%(14 mg/kg剂量组),随着剂量增加可能出现饱和现象.在设计三氮脒应用于猪的给药方案时应充分考虑这一因素.

       

      Abstract: 【Objective】A study on the diminazene-protein binding rate in swine was carried out in this experiment for further clinical application efficiency and safety.【Method】The plasma samples were pretreated to separate free drug by ultrafiltration. A high performance liquid chromatographic-UV (HPLC-UV) method was used to measure the amount of free diminazene in plasma. Then the drug-protein binding rate was accounted. Six swine were administrated intramuscularly at a dosages of 7 and 14 mg/kg. The plasma samples were collected and the protein binding rates in vivo were determination at 3, 5, 15, 60 min.【Result and conclusion】Diminazene-protein binding rate tested in vitro was within the range of 74.68%-95.90%. Although the drug-protein binding rate in vivo was within the range of 84.11%-89.69%(7 mg/kg, i.m.), and 82.96%-88.65%(14 mg/kg, i.m.) after administration, and saturation phenomenon emerged as dosage increased. These factors should be considered in clinical regimens designing.

       

    /

    返回文章
    返回